CRBP (STOCKS)
Corbus Pharmaceuticals Holdings, Inc.
$10.180000
+0.380000 (+3.88%)
Prev close: $9.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Yuval Cohen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $180.91M
- Employees
- 28
- P/E (TTM)
- -1.70
- P/B (TTM)
- 1.17
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.53M |
| Benefits Costs and Expenses | $84.07M |
| Costs And Expenses | $84.07M |
| Nonoperating Income/Loss | $6.77M |
| Operating Expenses | $85.31M |
| Depreciation and Amortization | $233.00K |
| Research and Development | $70.10M |
| Other Operating Expenses | $14.98M |
| Operating Income/Loss | -$85.31M |
| Income/Loss From Continuing Operations After Tax | -$78.54M |
| Income/Loss From Continuing Operations Before Tax | -$78.54M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$78.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$78.54M |
| Net Income/Loss Attributable To Parent | -$78.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$78.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.90 |
| Diluted Earnings Per Share | -$5.90 |
| Basic Average Shares | 13,317,116 |
| Diluted Average Shares | 13,317,116 |
| Assets | $168.20M |
| Current Assets | $166.95M |
| Noncurrent Assets | $1.24M |
| Fixed Assets | $159.00K |
| Other Non-current Assets | $1.08M |
| Liabilities | $20.69M |
| Current Liabilities | $20.69M |
| Accounts Payable | $2.22M |
| Wages | $2.86M |
| Other Current Liabilities | $15.62M |
| Noncurrent Liabilities | $0.00 |
| Equity | $147.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $147.50M |
| Liabilities And Equity | $168.20M |
| Net Cash Flow From Operating Activities | -$64.49M |
| Net Cash Flow From Operating Activities, Continuing | -$64.49M |
| Net Cash Flow From Investing Activities | -$1.64M |
| Net Cash Flow From Investing Activities, Continuing | -$1.64M |
| Net Cash Flow From Financing Activities | $77.43M |
| Net Cash Flow From Financing Activities, Continuing | $77.43M |
| Net Cash Flow | $11.29M |
| Net Cash Flow, Continuing | $11.29M |
| Comprehensive Income/Loss | -$78.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$78.63M |
| Other Comprehensive Income/Loss | -$88.00K |